Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6587-6594
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Figure 3 Changes of serum ferritin and transferrin saturation.
The patient’s serum ferritin was as high as 1252.2 mg/L on the second day after blood transfusion on July 25, 2020. His iron index was further improved after taking roxadustat orally in the following months. SF: Serum ferritin; TAST: Transferrin saturation.
- Citation: Zhou QQ, Li J, Liu B, Wang CL. Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report. World J Clin Cases 2022; 10(19): 6587-6594
- URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6587.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i19.6587